Marc Penn

Devices & Diagnostics

Cleveland HeartLab at TEDMED (video)

Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers taking the company’s heart inflammation tests. Results of the TEDMED tests showed that 41 percent of those who submitted samples had high cholesterol or low HDL (good cholesterol), 28 percent showed evidence of hardening of the arteries and 12 percent […]


Regenerative medicine company encouraged by heart failure trial

Regenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure patients treated with the company’s stem cell therapy showed “significant” improvements in two key measures — a six-minute distance-walking test, as well as the Minnesota Living with Heart […]


Cleveland Clinic physician-entrepreneur Marc Penn leaving CCF

One of Northeast Ohio’s leading physician-entrepreneurs is leaving Cleveland Clinic to join Akron’s Summa Health System. Dr. Marc Penn will become director of research for the Summa Cardiovascular Institute and also a professor at Northeast Ohio Medical University (NEOMED) in Rootstown, according to a statement from Summa. Penn will start with Summa next month. His […]